press articles|articoli stampa

  

  
51 - 60 of 66 Results

  1. Study Finds No Cancer Link To Sweetener   View Pdf d
    The New York Times, April 08, 2006

  2. Le Onde dei Cellulari fanno Male? Chiedete a questi Topi   View Pdf d
    Il Venerdì di Repubblica, March 10, 2006

  3. X-File sull’Aspartame   View Pdf d
    Economy, March 08, 2006

  4. Sour Finding on Popular Sweetener: Increased Cancer Incidence Associated with Low-Dose Aspartame Intake   View Pdf d
    Science Selections, Environmental Health Perspectives, March 01, 2006

  5. Ramazzini, Ricerca di Qualità   View Pdf d
    Bologna Economica, March 01, 2006

  6. Gli Effetti Cancerogeni Multipotenti dell’Aspartame   View Pdf d
    L’Ecologist Italiano, March 01, 2006

  7. Editorial: The Safety of Aspartame   View Pdf d
    New York Times, February 21, 2006

  8. Not So Sweet Anymore: Aspartame Under Fire. Study Reignites Dispute Over Cancer Risk   View Pdf d
    International Herald Tribune, February 13, 2006

  9. The Lowdown on Sweet. A Study Rekindles Debate Over Aspartame   View Pdf d
    New York Times, February 12, 2006

  10. Les Risques de l'Aspartame   View Pdf d
    Le Monde, December 14, 2005

Page: 1 | 2 | 3 | 4 | 5 | 6 | 7   Prev Next

November 15, 2008
EHP commentary argues the limits of 2-year bioassay exposure regimens: Ramazzini lifespan studies aspartame and toluene cited.
In a recent commentary entitled "The limits of 2-Year Bioassay Exposure Regimens for Identifying Chemical Carcinogens"Environ Health Perspect 116:11, 2008, authors James Huff, Devra Davis and Michael Jacobson argue that the sensitivity of chemical carcinogenesis bioassays would be enhanced by exposing rodents beginning in utero and continuing for 30 months (130 weeks) or until their natural deaths at up to about 3 years. Citing lifespan studies conducted by the European Ramazzini Foundation on aspartame and toluene the authors conclude that observing rodents until their natural deaths (i.e the Ramazzini lifespan model) increases the sensitivity of bioassays, avoids false-negative results, and strengthens the value and validity of results for regulatory agencies.
archive/archivio